Study of platelet aggregation in acute coronary syndrome with special reference to metabolic syndrome

BACKGROUND/CONTEXT: Antiplatelet drug resistance increases the risk of adverse events like stent thrombosis in acute coronary syndrome (ACS). Metabolic syndrome (MS) is a prothrombotic state and presence of MS further increases the risk of antiplatelet drug resistance. AIMS AND OBJECTIVES: We studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Rudrajit, Banerjee, Amit K, Guha, Shantanu, Chaudhuri, Utpal, Ghosh, Srabani, Mondal, Jayati, Bandyopadhyay, Ramtanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783664/
https://www.ncbi.nlm.nih.gov/pubmed/24083147
http://dx.doi.org/10.4103/2229-516X.117086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783664/
https://www.ncbi.nlm.nih.gov/pubmed/24083147
http://dx.doi.org/10.4103/2229-516X.117086

Ejemplares similares